单磷酸阿糖腺苷联合利巴韦林治疗手足口病40例疗效观察  

Therapeutic Effects of Ara-Amp Combined With Ribavirin for the Treatment of Hand-foot-mouth Disease

作　　者：钟哲峰[1] 何剑[1] 周安民[1] 

机构地区：[1]南华大学附属南华医院感染科,湖南衡阳421002

出　　处：《中南医学科学杂志》2012年第2期188-189,共2页Medical Science Journal of Central South China

摘　　要：目的观察单磷酸阿糖腺苷联合利巴韦林治疗手足口病的疗效。方法回顾性分析80例手足口病患儿临床资料,对照组40例予以利巴韦林治疗,实验组40例予以单磷酸阿糖腺苷联合利巴韦林治疗。结果两组在总有效率上无明显差别(P>0.05);但是实验组显效率、临床症状消退时间均明显优于对照组(P<0.05)。结论单磷酸阿糖腺苷联合利巴韦林治疗小儿手足口病疗效确切,未见明显不良反应。Objective To study the efficacy of Ara-Amp combined with Ribavirin injection in treatment of HFMD.Method 80 child patients who suffered from pathogen on HFMD were randomly divided into 2 groups,control group（40 cases）and treatment group（40 cases）.Ribavirin injection was used in control group and Ara-Amp combined with Ribavirin injection were used in treatment group.Result There was no difference in the total effective rate between the two groups（P0.05）,Clinical symptom regression times and notable effective rates of treatment group are better than those of control group.There was a statistically significant difference between the two groups（P0.05）.Conclusion Ara-Amp combined with Ribavirin injection were used in treatment of HFMD in child patients showed good Clinical efficacy and no adverse reaction.

关 键 词：手足口病 单磷酸阿糖腺苷 利巴韦林 

分 类 号：R725.1[医药卫生—儿科]